Charles B O'keeffe - Net Worth and Insider Trading
Charles B O'keeffe Net Worth
The estimated net worth of Charles B O'keeffe is at least $9 Million dollars as of 2024-06-10. Charles B O'keeffe is the Director of Catalyst Pharmaceuticals Inc and owns about 565,057 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $9 Million. Details can be seen in Charles B O'keeffe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles B O'keeffe has not made any transactions after 2022-11-15 and currently still holds the listed stock(s).
Transaction Summary of Charles B O'keeffe
Charles B O'keeffe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles B O'keeffe owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Charles B O'keeffe’s form 4 insider trades.
Insider Ownership Summary of Charles B O'keeffe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-15 | director |
Charles B O'keeffe Latest Holdings Summary
Charles B O'keeffe currently owns a total of 1 stock. Charles B O'keeffe owns 565,057 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 15, 2022, with a value of $9 Million.
Latest Holdings of Charles B O'keeffe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-15 | 565,057 | 15.23 | 8,605,818 |
Holding Weightings of Charles B O'keeffe
Charles B O'keeffe Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles B O'keeffe has made a total of 3 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 87,985 shares on November 15, 2022, which brought Charles B O'keeffe around $1 Million.
Insider Trading History of Charles B O'keeffe
- 1
Charles B O'keeffe Trading Performance
GuruFocus tracks the stock performance after each of Charles B O'keeffe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles B O'keeffe is 21.11%. GuruFocus also compares Charles B O'keeffe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles B O'keeffe within 3 months outperforms 15 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles B O'keeffe's insider trading performs compared to the benchmark.
Performance of Charles B O'keeffe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.63 | | | | | |
| Relative Return to S&P 500(%) | 7.76 | | | | | |
Charles B O'keeffe Ownership Network
Charles B O'keeffe Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Charles B O'keeffe is the director of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Medical Officer Gary Ingenito , Chief Compliance/Legal Officer Brian Elsbernd , and Chief Accounting Officer Alicia Grande .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Charles B O'keeffe made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 250,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 130,000 shares made by Gary Ingenito .
In summary, during the past 3 months, insiders sold 152,656 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 152,656 shares. During the past 18 months, 702,807 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 702,807 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Charles B O'keeffe Mailing Address
Above is the net worth, insider trading, and ownership report for Charles B O'keeffe. You might contact Charles B O'keeffe via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
